Skip to main content

Peer Review reports

From: Boronic prodrug of 4-hydroxytamoxifen is more efficacious than tamoxifen with enhanced bioavailability independent of CYP2D6 status

Original Submission
10 Apr 2015 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Author responded Author comments
Reviewed Reviewer Report
Reviewed Reviewer Report
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
21 Aug 2015 Editorially accepted
9 Sep 2015 Article published 10.1186/s12885-015-1621-2

You can find further information about peer review here.

Back to article page